Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
greeen day today in the markets imho ...eom
POZN - $6.17 > price target $15
Analyst Eun K. Yang with Jefferies and Company Inc. wrote in a Monday note to clients that the stock is oversold. Yang predicts the drug will not cause any serious safety issues because its main ingredients are two already marketed pain relieving drugs, though he noted that the exact nature of the FDA's inquiry is unknown.
Yang rated the stock at "Buy" and also lowered his price target to $15 from $20. He predicts Trexima, which is Pozen's lead product candidate, will be on the market in early 2008, about 15 months later than previously anticipated.
I F L T --- volume alert ...eom
IFLT -01x011 moving on volume !!...eom
POZN - pre market action ..eom
POZN - rollin
for a stock with only 29 million shares outstanding
volume friday was 26 million
today 13 milllion
shorts goona have to cover
POZN -- pre market runnning
looks good to make up some ground today
oversold big bounce coming
http://stockcharts.com/h-sc/ui?s=pozn
hey ilikebb -POZN
i cant belive they killled it so bad... i bought 3000 shares(average 5.44 ) and will flip them monday when people come to there sense's ...lolololol
have a great weekend to all!!!!
POZEN INC. AND GLAXOSMITHKLINE REPORT RECEIPT OF APPROVABLE LETTER FOR INVESTIGATIONAL
MIGRAINE TREATMENT
CHAPEL HILL, NC and RESEARCH TRIANGLE PARK, NC, JUNE 9, 2006 -- POZEN Inc. (NASDAQ: POZN) and GlaxoSmithKline (NYSE: GSK) announced today that the U.S. Food and Drug Administration (FDA) has issued an approvable letter for Trexima ™. An approvable letter is an official notification from the FDA that contains conditions that must be satisfied prior to obtaining final U.S. marketing approval.
The FDA has determined that Trexima is effective as an acute treatment for migraine headaches. The Agency has requested additional safety information on Trexima , which may require new studies. POZEN and GSK intend to request a meeting with the FDA as quickly as possible to discuss the approvable letter and determine the appropriate next steps to gain full approval.
Trexima, the proposed brand name for the product candidate combining sumatriptan 85 mg, as the succinate salt, formulated with RT Technology™ and naproxen sodium 500 mg in a single tablet, is the first product designed to treat multiple mechanisms of migraine: inflammation and vasodilation.
About Imitrex® (sumatriptan succinate) Tablets
Imitrex is a prescription medication indicated for the acute treatment of migraine in adults. Imitrex should only be used when a clear diagnosis of migraine has been established. Patients should not take Imitrex if they have certain types of heart disease, history of stroke or TIAs, peripheral vascular disease, Raynaud syndrome, or blood pressure that is uncontrolled. Patients with risk factors for heart disease, such as high blood pressure, high cholesterol, diabetes or are a smoker, should be evaluated by a doctor before taking Imitrex. Very rarely, certain people, even some without heart disease, have had serious heart related problems. Patients who are pregnant, nursing, or taking medications should talk to their doctor.
- 1 -
About Naproxen Sodium
Naproxen sodium is a non-steroidal anti-inflammatory drug (NSAID) and is contained in Anaprox®, Anaprox DS®, Naprelan®, Aleve® and in a number of over-the-counter medications. Naproxen sodium is indicated for the treatment of rheumatoid arthritis, osteoarthritis, ankylosing spondylitis and juvenile arthritis. It is also indicated for the treatment of tendinitis, bursitis, acute gout and for the management of pain and primary dysmenorrhea. Naproxen-containing products should not be used by patients who have had allergic reactions to any product containing naproxen, nor in patients in whom aspirin or other NSAIDs induce the syndrome of asthma, rhinitis, and nasal polyps. Patients who have a history of peptic ulcer or gastrointestinal bleeding, kidney problems, uncontrolled hypertension or heart failure should consult a physician before using naproxen-containing medications. NSAIDs may cause increased risk of serious cardiovascular thrombotic events, myocardial infarction and stroke. This risk may increase with duration of use and in patients with cardiovascular disease or risk factors for cardiovascular disease. Serious gastrointestinal toxicity such as bleeding, ulceration and perforation can occur at any time in patients treated chronically with NSAID therapy and physicians should remain alert for such effects even in the absence of previous GI tract symptoms. Patients who are pregnant or are nursing should consult a physician before use of a naproxen-containing medication.
About GlaxoSmithKline
GlaxoSmithKline - one of the world's leading research-based pharmaceutical and healthcare companies - is committed to improving the quality of human life by enabling people to do more, feel better and live longer. For detailed company information, see GlaxoSmithKline's website: www.gsk.com.
About POZEN
POZEN is a pharmaceutical company committed to developing therapeutic advancements for diseases with unmet medical needs where it can improve efficacy, safety, and/or patient convenience. POZEN’s efforts are focused primarily on the development of pharmaceutical products for the treatment of acute and chronic pain and other pain related conditions. The company's common stock is traded on The Nasdaq Stock Market under the symbol "POZN".
For detailed company information, including copies of this and other press releases, see POZEN's website: www.pozen.com .
SRGE - surging !!!!...eom
LCST ...001 x0014 ..eom
EDEX - 20 day ready to break 200
get ready
SMXT 004x005 ----low float ..eom
SMXT - oilfield security in kuwait ..eom
SMXT 004 x005- heads up ...eom
PRRPF
keep your eyes on it ....
The company has no long-term debt and has credits and cash on hand for additional drilling or acquisitions.
Webcast Alert: Portrush Petroleum Corporation Announces Its InformedInvestors.com Presentation Webcast
Last Update: 3:54 PM ET May 9, 2006
May 9, 2006 (CCNMatthews via COMTEX) -- Portrush Petroleum Corporation (PRRPF)
portrush pete corp com
PRRPF-0.16, +0.00, +1.9% ) announces the following Webcast:
What: Portrush Petroleum Corporation InformedInvestors.com Presentation Webcast
When: May 11, 2006 @ 12:30 PM Eastern
Where: www.vcall.com/EventPage.asp?ID=104358
How: Live over the Internet -- Simply log on to the web at the address above.
Presenter: Martin P. Cotter, President of Portrush Petroleum Corporation
IR Contact: Paul Kondakos, www.agoracom.com/ir/portrush, email: PSH@agoracom.com
If you are unable to participate during the live webcast, the call will be available for replay at www.vcall.com/ClientPage.asp?ID=104358 or http://www.investorcalendar.com/
Portrush Petroleum (TSX Venture Exchange: PSH / OTC: PRRPF) is a rapidly growing oil and natural gas production company that is focused on low risk, high reward oil and gas exploration and production in North America. The company has no long-term debt and has credits and cash on hand for additional drilling or acquisitions. Portrush's mandate is to become a mid-range oil and gas producer. The Company's core producing properties are in the Michigan Basin, Michigan and the Gulf Coast, Texas.
The Company invests in oil and gas related operations; acquires interests in properties to determine the existence, location, extent and quality of the oil and gas resources located on the properties; and will drill, complete and participate in the operation of or development of oil and gas wells and related operations.
Portrush's mission is to participate in full cycle exploration for and development of North American oil and natural gas reserves. Portrush is headed up by President, Martin Cotter, a professional engineer with extensive experience in the Canadian Oil and Gas Industry. Technical expertise is provided by several highly qualified and experienced independent explorationists. The functions of the executive team are to draw on and direct the technical resources of joint venture partners to ensure that Portrush shareholders' funds are invested to maximize value. The Corporation's overall objective is to see that all dollars raised go directly into the ground rather than into corporate overhead.
SOURCE: Portrush Petroleum Corporation
Forum Contact: Nancy Christman WI Link / Informed Investors (804) 327-3410 nchristman@wilink.com www.informedinvestors.com Copyright (C) 2006 CCNMatthews. All rights reserved. End of Story
90 foot oil column...wow ...
off shore north sea ... nice its up big over seas
you can buy shares under
" oilxf " on the pink sheets
Oilexco Intersects Significant Oil Column at Disraeli
5/8/2006
CALGARY, ALBERTA, May 8, 2006 (CCNMatthews via COMTEX News Network) --
Oilexco Incorporated ("Oilexco") (TSX:OIL) (AIM:OIL) announces it has intersected a significant oil column at its 65% owned Disraeli Prospect located in Block 21/23a in the UK Central North Sea.
An approximately 90 foot oil column was intersected by the first Disraeli side-track well bore 21/23a-8Z in the Eocene Tay Sandstone, located on the west flank of a structure defined by 3D seismic data. The 21/23a-8Z well bore is presently being plugged back to allow an additional side-track well bore to be drilled to evaluate the oil column at crest of the structure. Operations on the second sidetrack 21/23a-8Y are expected to be completed in seven days time.
SFDE - now 022 ..eom
just add more STDE @013 ..gifts ..eom
in EDEX--bounce ..eom
in FMLY ...loooks good"chart" ..eom
added more SFDE ...ethanol rumors fwiw ..eom
sfde - nice shake out ..now we continue ..imho
SFDE-- were on the road to 50 cents ..imho
SFDE 05....very low float!!!
SFDE- Stafford Energy, Inc
04 and going again
p.s- EXALF
they currently have 3 drills turning on the property and raised 30 million dollars and there ready to release 4 or 5 holes results in the next 1 to 7 days . we get result like last time with 650 gold look out
good luck
http://stockcharts.com/h-sc/ui?s=exl.to
EXALF- on the pinks
big long white candle ... mac d cross'd over ... looks like a very long run coming ...imho
its a gold stock that some call the next "goldcorp" .they are drilling lands that is a completly surrounded by
(GG) Goldcorp on the nyse.. the property is in red lake canada
right next to goldcorp major mines. look at the results there pulling out . goldcorp has to be ready to pounce and take them out .IMHO at some point in time
8.50 oz/ton over 8.01 feet is amazing grades
Exall Resources Limited: Significant Results Continue at Gold Eagle Property in Red Lake, Ontario
3/6/2006
TORONTO, ONTARIO, Mar 6, 2006 (CCNMatthews via COMTEX) --
Exall Resources Limited (TSX:EXL)(OTCBB:EXALF) and Southern Star Resources Inc. (TSX VENTURE:SSR) are pleased to announce that the on-going drill program at the Gold Eagle Mine Property in Red Lake, Ontario continues to intersect significant widths of high-grade gold: 291.4 grams/tonne over 2.44 metres (8.50 oz/ton over 8.01 feet) and also discovered a new high-grade sulphide-hosted type of gold mineralization:
EDEX -news
Eldorado Exploration to Drill in Texas
5/3/2006
IRVINE, Calif., May 03, 2006 (BUSINESS WIRE) --
Eldorado (Pink Sheets:EDEX) announced today that it will participate in drilling an 8000' test of the Wolfcamp formation in Glasscock County, Texas. Expected drill date for the well is week three of June 2006. The prospect is based on analysis of Passive Induced Polarization (PIP), radiometrics, passive reflection seismology and subsurface geology.
PIP is a geophysical prospecting method that can indicate the presence of significant hydrocarbons from the surface. After reviewing oil production from the adjoining field, the PIP process was conducted to determine the potential for additional development. The PIP analysis indicated a channel over three miles long that may be an unexplored extension of the producing field. Three nearby wells have produced over 1 million barrels each over the past 10 years and are flowing at a combined rate of 45,000 barrels per month.
For further information about the company visit www.eldoradoexploration.com or e-mail at eldoex@yahoo.com.
Please be advised that statements made herein, other than historical data, constitute forward-looking statements that involve risks and uncertainties that could cause actual results to differ materially from those stated or implied by such forward-looking statements. The potential risks and uncertainties include, among others, potential volatility in the company's stock price, increased competition, customer acceptance of new products and services offered by the company, and uncertainty of future revenue and profitability and fluctuations in its quarterly operating results. Please also be advised that Eldorado Exploration is a non-reporting Pink Sheets company and is not required to be registered with the Securities and Exchange Commission.
SOURCE: Eldorado Exploration
Eldorado Exploration Inc. David (Tom) Laurance, 949-916-0680 www.eldoradoexploration.com
Copyright Business Wire 2006
SFDE - getting wiggy ...eom
usxp - 9999 acca bid
looks like a bottom ..
im in for a flip
oil and gas ---PRRPF
its cheap and undiscovered only 40 million o/s !!!!
volume increasing ...something is up
http://stockcharts.com/h-sc/ui?s=PRRPF%20%20
another bottom play guys
looks prime to break out for all the chart guys and gals ...imho....
http://stockcharts.com/h-sc/ui?s=gnbt
if EDEX breaks 027 area where of to the races ..eom
EDEX- first well is paid for
great deal for EDEX... first well is paid for !!!!
no cost to EDEX ...
extremly low market cap only 3 million dollar and they have a potential of 8 billion dollar in gas ?
market will wake up sooner of later
Eldorado Exploration Announces Joint Venture
3/20/2006
IRVINE, Calif., Mar 20, 2006 (BUSINESS WIRE) --
Eldorado Exploration (Pink Sheets:EDEX) has entered into a joint venture with a private capital group to fund the drilling of the company's Mesa gas prospect in Roosevelt County, N.M.
The investors will earn half of Eldorado's 75 percent working interest for funding the drilling cost of the first well on the 11,000+ acres currently leased. After a discovery, Eldorado will pay its percentage share on any future wells drilled.
EDEX ..now 024
The Mesa prospect is on a PIP-identified Pennsylvanian Carbonate Reef that is over 25,000 acres in size. The company and its partners have over 11,000 net acres under lease over the heart of the structure. The possible reserves could be over 1 trillion cubic feet of recoverable gas, which at today's price of $8 per MCF would equate to $8 billion. Eldorado Exploration has a net 35 percent working interest in the well and surrounding acreage.
have a good day ..eom
EDEX - oil play .02
1 trillion cubic ft of gas!!!
comming off bottom
http://stockcharts.com/h-sc/ui?s=edex
EDEX - macd ready to cross over
alerted on another board ...looks like bottom
oil and gas play
http://stockcharts.com/h-sc/ui?s=edex